0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Therapy for Neutropenia in Hairy Cell Leukemia with Recombinant Human Granulocyte Colony-Stimulating Factor

John A. Glaspy, MD; Gayle C. Baldwin, PhD; Paul A. Robertson, MD; Lawrence Souza, PhD; Martha Vincent, PhD; Janice Ambersley, RN; and David W. Golde, MD
[+] Article and Author Information

Grant support: Supported in part by grants CA 32737 and CA 30388 from the National Institutes of Health, State of California University-wide Task Force on AIDS, and by a contract from Amgen Inc., Thousand Oaks, California.

Requests for Reprints: John A. Glaspy, MD, Room 42-121 CHS, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, California 90024-1678.

Current Author Addresses: Drs. Glaspy, Baldwin, and Ms. Ambersley: Room 42-121, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90024-1678,

Dr. Robertson: Room 42-158, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90024-1678.

Drs. Souza and Vincent: 1900 Oak Terrace Lane, Thousand Oaks, CA 91320.

Dr. Golde: Room 37-068 CHS, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90024-1678.


© 1988 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1988;109(10):789-795. doi:10.7326/0003-4819-109-10-789
Text Size: A A A

Study Objective: To determine whether recombinant human granulocyte colony-stimulating factor (G-CSF) is effective in increasing neutrophil counts in patients with hairy cell leukemia and neutropenia.

Design: Open label, phase I/II study of G-CSF, given by daily subcutaneous injection for up to 7 weeks.

Setting: Outpatient oncology clinic of a university medical center.

Patients: A consecutive sample of four patients with hairy cell leukemia complicated by severe neutropenia. Three patients completed the study; one patient was removed after 2 weeks of therapy.

Interventions: Granulocyte colony-stimulating factor was given by daily subcutaneous injection. Each patient began therapy with 1 µg/kg body weight ·d; after 1 week the dose was increased to 3 µg/kg ·d, and 1 week later to 6 µg/ kg ·d. Therapy was continued for 5 to 6 weeks. Patients were taught self-injection, and administered treatment at home.

Measurements and main results: In three patients, an increase in absolute neutrophil counts from less than 0.9 X 10/L to greater than 4.0 X 10/L was noted within 2 weeks of beginning G-CSF therapy. In two patients, infections resolved during therapy. One patient developed acute neutrophilic dermatosis (the Sweet syndrome) while receiving 3 µg/kg ·d of G-CSF, and drug therapy was discontinued.

Conclusions: Granulocyte colony-stimulating factor may increase neutrophil counts within 2 weeks in patients with hairy cell leukemia and neutropenia. This therapy may be a useful adjunct to definitive treatment of hairy cell leukemia with interferon or pentostatin.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)